Category: ROOT

Automation, delegation of certain nursing tasks could help close workforce gap

Tech enablement, or automation, and improved delegation of tasks have the potential to free up to 15 percent of nurses’ time.

Johnson & Johnson venture arm names new resident company

Johnson & Johnson Innovation, the venture capital and incubator arm of Johnson & Johnson, named biotherapeutics company Ceramedix a resident company. 

Value-based healthcare platform raises $45M

Carrum Health, a value-based care platform, raised $45 million in an oversubscribed series B financing round.

UMass Memorial to close maternity ward

UMass Memorial Health plans to close the maternity ward at its HealthAlliance-Clinton Hospital on Sept. 22 due to staff shortages and a declining number of births in the area, the Worcester Business Journal reported May 30.

Some oncologists are rationing cancer drugs as shortages grow

Some oncologists are rationing cancer drugs and delaying patient treatment as the shortages grow worse, NBC News reported May 28.

HCA names CFO of Florida hospital

HCA Florida University Hospital, a 165-bed facility in Davie, appointed Danny Fischesser CFO, effective June 19.

220 Americans underwent procedures at Mexico ASC under investigation for meningitis outbreak, CDC says

The CDC is currently collaborating with the Mexican Ministry of Health and U.S. state and local health departments to investigate an outbreak of fungal meningitis among patients who had surgical procedures under epidural anesthesia at River Side Surgic…

Texas governor signs medical billing transparency legislation

Texas Gov. Greg Abbott has signed a bill into law that will require hospitals to provide an itemized bill when billing for medical services. 

BenevolentAI to cut about 180 jobs

BenevolentAI plans to lay off about 180 employees as the company also reduces its lab footprint and stops some drug discovery programs.

Next COVID-19 shot might cut original strain, focus only on XBB.1

Health experts are hoping the next altered COVID-19 vaccine will return to being monovalent but focus solely on XBB.1, The Atlantic reported May 26.